@article{article521cd97c,
title   = {Health-related quality of life in KEYNOTE-010: a phase II/III study of Pembrolizumab versus Docetaxel in patients with previously treated advanced, programmed death ligand 1-Expressing NSCLC},
author = {Barlesi, Fabrice and Garon, Edward B and Kim, Dong-Wan and Felip, Enriqueta and Han, Ji-Youn and Kim, Joo-Hang and Ahn, Myung-Ju and Fidler, Mary Jo and Gubens, Matthew A. and Castro Junior, Gilberto de},
year = {2019},
doi = {10.1016/j.jtho.2019.01.016},
journal   = {Journal of thoracic oncology}
}